TD Asset Management
MDGL icon

TD Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

TD Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Sell
9,134
-2,958
-24% -$1.52M ﹤0.01% 811
2026
Q1 		$6.33M Buy
12,092
+1,706
+16% +$815K 0.01% 753
2025
Q4 		$6.05M Sell
10,386
-2,938
-22% -$1.5M ﹤0.01% 762
2025
Q3 		$6.11M Sell
13,324
-9,916
-43% -$3.7M 0.01% 751
2025
Q2 		$7.03M Buy
23,240
+1,000
+4% +$298K 0.01% 714
2025
Q1 		$7.37M Sell
22,240
-4,090
-16% -$1.34M 0.01% 709
2024
Q4 		$8.12M Sell
26,330
-11,800
-31% -$3.32M 0.01% 695
2024
Q3 		$8.1M Sell
38,130
-17,600
-32% -$4.5M 0.01% 685
2024
Q2 		$15.6M Buy
55,730
+5,400
+11% +$1.29M 0.01% 544
2024
Q1 		$13.4M Buy
50,330
+34,790
+224% +$8.2M 0.01% 570
2023
Q4 		$3.6M Buy
+15,540
New +$2.72M ﹤0.01% 828
2021
Q1 		– Sell
-4,800
Closed -$534K – 1523
2020
Q4 		$534K Hold
4,800
– – ﹤0.01% 1321
2020
Q3 		$570K Buy
4,800
+1,595
+50% +$173K ﹤0.01% 1205
2020
Q2 		$363K Buy
+3,205
New +$315K ﹤0.01% 1251
2019
Q3 		– Sell
-5,988
Closed -$628K – 1354
2019
Q2 		$628K Buy
5,988
+100
+2% +$10.7K ﹤0.01% 1144
2019
Q1 		$738K Sell
5,888
-600
-9% -$74.6K ﹤0.01% 1100
2018
Q4 		$731K Sell
6,488
-6,904
-52% -$1.07M ﹤0.01% 1136
2018
Q3 		$2.87M Sell
13,392
-3,408
-20% -$855K ﹤0.01% 898
2018
Q2 		$4.7M Buy
16,800
+8,600
+105% +$1.51M 0.01% 721
2018
Q1 		$958K Buy
+8,200
New +$1.01M ﹤0.01% 1074

Other funds holding MDGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management's MDGL Position: Q2 2026 in Review

TD Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 24% in Q2 2026, selling an estimated $1.52M and leaving 9,134 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #811.

TD Asset Management first reported a position in MDGL in Q1 2018 and has held it in 20 quarters since. The position peaked at $15.6M in Q2 2024. 281 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • TD Asset Management held 9,134 shares of Madrigal Pharmaceuticals worth $4.9M as of Q2 2026.
  • TD Asset Management sold 2,958 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.52M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #811 holding.
  • TD Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2018 and has held it in 20 quarters since.
  • TD Asset Management's Madrigal Pharmaceuticals position peaked at $15.6M in Q2 2024.
  • 281 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.